Thermo Fisher Q4 Revenues Climb 6 Percent; Mum on Life Tech Speculation | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that revenues in the fourth quarter improved 6 percent year over year as its Specialty Diagnostics segment saw 12 percent growth.

Revenues for the quarter ended Dec. 31, 2012 totaled $3.26 billion, up from $3.09 billion a year ago, topping the consensus Wall Street estimate of $3.14 billion. Organically, revenues were up 4 percent year over year, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.